Search
Descriptor English: Uric Acid
Descriptor Spanish: Ácido Úrico
Descriptor ácido úrico
Entry term(s) 2,6,8-trihidroxipurina
trioxopurina
urato
urato de potasio
urato de sodio
urato de sodio monohidratado
urato monosódico
urato monosódico monohidratado
urato ácido de amonio
urato ácido de sodio
urato ácido de sodio monohidratado
Scope note: Producto de oxidación, vía XANTINO OXIDASA, de oxipurinas tales como la XANTINA y la HIPOXANTINA. Se trata del producto final de oxidación del catabolismo de la purina en los seres humanos y los primates, mientras que en la mayoría del resto de mamíferos la URATO OXIDASA lo oxida para dar ALANTOÍNA.
Descriptor Portuguese: Ácido Úrico
Descriptor French: Acide urique
Entry term(s): 2,6,8-Trihydroxypurine
Acid Urate, Ammonium
Acid Urate, Sodium
Acid, Uric
Ammonium Acid Urate
Monohydrate, Monosodium Urate
Monohydrate, Sodium Urate
Monosodium Urate
Monosodium Urate Monohydrate
Potassium Urate
Sodium Acid Urate
Sodium Acid Urate Monohydrate
Sodium Urate
Sodium Urate Monohydrate
Trioxopurine
Urate
Urate Monohydrate, Monosodium
Urate Monohydrate, Sodium
Urate, Ammonium Acid
Urate, Monosodium
Urate, Potassium
Urate, Sodium
Urate, Sodium Acid
Tree number(s): D03.132.960.877
D03.633.100.759.758.824.877
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D014527
Scope note: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antioxidants
Registry Number: 268B43MJ25
CAS Type 1 Name: 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-
Related: Uricum Acidum DeCS
DeCS ID: 14926
Unique ID: D014527
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/06/22
Uric Acid - Preferred
Concept UI M0022340
Scope note An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
Preferred term Uric Acid
Entry term(s) 2,6,8-Trihydroxypurine
Acid, Uric
Trioxopurine
Potassium Urate - Narrower
Concept UI M0022338
Preferred term Potassium Urate
Entry term(s) Urate, Potassium
Urate - Narrower
Concept UI M0022341
Preferred term Urate
Ammonium Acid Urate - Narrower
Concept UI M0022337
Preferred term Ammonium Acid Urate
Entry term(s) Acid Urate, Ammonium
Urate, Ammonium Acid
Sodium Urate Monohydrate - Narrower
Concept UI M0022339
Preferred term Sodium Urate Monohydrate
Entry term(s) Acid Urate, Sodium
Monohydrate, Monosodium Urate
Monohydrate, Sodium Urate
Monosodium Urate
Monosodium Urate Monohydrate
Sodium Acid Urate
Sodium Acid Urate Monohydrate
Sodium Urate
Urate Monohydrate, Monosodium
Urate Monohydrate, Sodium
Urate, Monosodium
Urate, Sodium
Urate, Sodium Acid



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey